askbio
PrivateLast Round
M&A
Oct 26, 2020
Last Round Size
$2B
Est. Valuation
$4B
Total Funding Raised
$2.24B
Company Overview
AskBio is a biopharmaceutical company specializing in the development and manufacturing of Adeno-Associated Virus (AAV) gene therapy therapeutics for rare and generally untreatable genetic disorders.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
askbio Comparables
Compare askbio with similar companies based on industry and business-model similarity.
No public comparables are available for askbio. Request access to learn about comparables coverage.
Book a demoFor institutional investors. Book with your work email.
askbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 26, 2020 | ||||
| Grant | Sep 2, 2020 | ||||
| Series A | Apr 11, 2019 | ||||
| Grant | Jul 22, 2004 |
For institutional investors. Book with your work email.
askbio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.